The previously published manuscript, “Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression,” was voted the Best Immune Cell Therapies and Immune Cell Engineering Paper of 2023 by the Journal for …
Capitini Research Group News
Christian Capitini receives grant to study potency of T cell therapies against cancer
The National Cancer Institute recently granted Christian Capitini, MD, associate professor and chief, Division of Hematology, Oncology, and Bone Marrow Transplant, an R01 award for his project, “Label-free Imaging of CAR T Cell Metabolism.” MPIs …
Christian Capitini receives ICTR Pilot Award to investigate immunotherapeutics targeting metastatic osteosarcoma
Christian Capitini, MD, associate professor and chief, Division of Hematology, Oncology, and Bone Marrow Transplant, and Sandro Mecozzi, PhD, professor of pharmaceutical sciences, were recently awarded a Translational Basic and Clinical Pilot Program award from …
Christian Capitini will lead Division of Hematology, Oncology, and Bone Marrow Transplant as newly named chief
The new academic year will bring a change in leadership for the Division of Hematology, Oncology, and Bone Marrow Transplant when Christian Capitini, MD, associate professor, assumes the role of division chief on July 1. …
UW researchers identify cell type that could be key to preventing marrow transplant complication
A bone marrow transplant can be a lifesaving treatment for people with relapsed blood cancers, but a potentially lethal complication known as graft-versus-host disease put limitations on this procedure. New research from the University of …
Becky Richards awarded ASH Fellow Scholar Award and NIH K08 grant for research in new CAR T cell therapy
The American Society of Hematology (ASH) has awarded Rebecca “Becky” Richards, MD, PhD, assistant professor, Division of Hematology, Oncology, and Bone Marrow Transplant, an ASH Fellow Scholar Award of $100,000 for the period October 1, …
CRISPR-produced CAR T cells could better treat solid tumors
Chimeric antigen receptor (CAR) T cells are biological assassins: white blood cells that are specifically engineered to attack cancer cells. Over the past five years, they’ve become an established therapeutic option for patients with blood …
Three department members honored with named professorships at the inaugural SMPH Faculty Investiture Ceremony
Named professorships endowed by donors to the University of Wisconsin School of Medicine and Public Health (SMPH) convey both an honor and funds to recipients’ research and other endeavors. On October 12, at the Fluno …
Four pediatrics faculty advisors, students receive Hilldale research fellowships
Congratulations to the following faculty and students who were recently awarded Hilldale Faculty/Undergraduate Research Fellowships for the 2022-2023 academic year. The fellowship provides research training and support to undergraduate students, and it provides them the …
Medical student Brittany Russell awarded POST grant to study in Capitini Lab
Congratulations to Brittany Russell, a medical student at the University of Wisconsin–Madison, and her mentor, Christian Capitini, MD, associate professor, Hematology, Oncology and Bone Marrow Transplant, who were recently awarded a $5,000 Pediatric Oncology Student Training (POST) …